Fox W
Postgrad Med J. 1971 Nov;47(553):729-36. doi: 10.1136/pgmj.47.553.729.
The advantages of intermittent chemotherapy for pulmonary tuberculosis are discussed and the results of several controlled trials summarized. Once-weekly therapy now appears a definite prospect. The most appropriate approach to therapy at both national and individual physician level now seems to be a combination of unsupervised daily and supervised intermittent regimens.
讨论了肺结核间歇化疗的优势,并总结了几项对照试验的结果。每周一次的治疗目前看来是一个明确的前景。现在,在国家和个体医生层面,最恰当的治疗方法似乎是将无监督的每日治疗方案和有监督的间歇治疗方案相结合。